Akumin Introduced Relocatable Radiation Therapy Center at RSNA
Akumin Inc. unveiled its first Akumin AXIS Relocatable & Expandable Outpatient Center, engineered to meet critical radiology and oncology requirements, at the RSNA meeting with a ribbon-cutting ceremony.
Designed and built in the US, Akumin AXIS is a fully equipped Outpatient Imaging or Radiation Therapy Center supporting many modalities, including PET-CTs, Linear Accelerators, and MRIs (in-progress). The layout enables high-volume scanning, with three uptake rooms for tracer and theranostic infusions, i.e., radioligand therapies. The first unit unveiled features Siemens Healthineers' Digital Biograph Trinion PET-CT scanner, with its air-cooled design making it an optimal solution for the Akumin AXIS solution. Akumin AXIS solves three key challenges faced by health systems today: large capital costs, construction time/delays, and staffing shortages.
"We are proud to unveil the world's first Akumin AXIS along with our Akumin Radiology Command Center at RSNA this year," said Krishna Kumar, CEO of Akumin. "This innovation expands possibilities and advances care for health systems by addressing some of the most pressing needs faced by hospitals in recent years. The interest and enthusiasm we've seen from attendees validate our core mission to innovate to enhance access to advanced imaging and oncology services for patients. We are delighted to collaborate with Siemens to further bring their new state-of-the-art digital PET-CT to the market."
"The Biograph Trinion PET-CT scanner delivers unparalleled precision and performance, while offering reduced siting and operational costs – making it a perfect fit for Akumin AXIS," said John Khoury, GM & VP of Siemens Healthineers Molecular Imaging and Theranostics, North America. "We're excited to collaborate with Akumin to bring this transformative solution to market and provide new opportunities for healthcare providers to enhance patient outcomes, as well as possibly enter new care pathways – such as theranostics."